Pharmaceutical sector faces risks from Strait of Hormuz closure
pre-market1 source ↓written by the desknot a recommendation
- generics making
- 90% of U.S. prescriptions
Volatility in the Middle East and the closure of the Strait of Hormuz have raised concerns about generic drug supplies. With generics making up 90% of U.S. prescriptions, the impact extends to branded pharmaceutical companies, which also rely heavily on petrochemical inputs for drug manufacturing. This situation highlights vulnerabilities across the pharmaceutical supply chain, affecting both production and logistics.
Not investment advice. For informational purposes only.